GeneNews (GEN) Stock Price, News & Analysis

Company Overview

Generation Uranium Inc. engages in the exploration and development of mineral properties. It has an option agreement to acquire a 60% interest in the Arlington property that comprises five mineral claims located in the Arrow Boundary District of south-central British Columbia, Canada; and holds a 100% interest in the YATH Uranium Property comprises five mineral claims that totaling approximately 8,438 hectares located in the territory of Nunavut. The company was formerly known as Generation Gold Corp. and changed its name to Generation Uranium Inc. in January 30, 2024. Generation Uranium Inc. was incorporated in 2018 and is based in Vancouver, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 473,147 shs
• Average Volume: 1.48 million shs
• Market Capitalization: C$25.49 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GEN Stock Analysis - Frequently Asked Questions

How do I buy shares of GeneNews?

Shares of GEN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of GeneNews own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GeneNews investors own include Marathon Digital (MARA), Ocugen (OCGN), Spero Therapeutics (SPRO), American Airlines Group (AAL), First Majestic Silver (AG) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: Computer Software
• Current Symbol: TSE:GEN
• CIK: N/A
• Web: www.genenews.com
• Phone: +1-905-7392030
• Fax: N/A
• Employees: 2,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.10
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: C$234.59 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 145.00
• Book Value: C($0.06) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 169,963,000
• Free Float: N/A
• Market Cap: C$25.49 million
• Optionable: Not Optionable
• Beta: N/A